Schisandra for Liver Health
Verdict: Taiwan Regulatory Restriction
Across 2 PubMed studies, the evidence for Schisandra in Liver Health grades Tier C — weak evidence.
C 🟠 C Weak Evidence Taiwan Regulatory Restriction
Why this grade7-layer evidence engine
⚖️
Scoring transparency
All scores computed by a 7-layer evidence engine — fully auditableRaw score 0.54
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Taiwan Regulatory Restriction
Confidence
50%
Conflicting evidence
Evidence level
E3
Single high-quality meta-analysis
▸View the full decision path (audit trail)
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.535
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
PubMed studies (2)L2 · primary research & systematic reviews
Efficacy of Schisandra chinensis in liver injury: a systematic review and preclinical meta-analysis
Finding: Significant ALT reduction vs model controls (SMD -4.74, p<0.001); also lowered MDA, TNF-a, IL-6, raised SOD/GSH.
View on PubMed Improvement of Liver Function in Humans Using a Mixture of Schisandra Fruit Extract and Sesamin
— See PubMed for details
View on PubMed